Page last updated: 2024-11-04

vorinostat and Dermatitis, Contact

vorinostat has been researched along with Dermatitis, Contact in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Dermatitis, Contact: A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lucas, JL1
Mirshahpanah, P1
Haas-Stapleton, E1
Asadullah, K1
Zollner, TM1
Numerof, RP1

Other Studies

1 other study available for vorinostat and Dermatitis, Contact

ArticleYear
Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.
    Cellular immunology, 2009, Volume: 257, Issue:1-2

    Topics: Animals; Benzamides; CD28 Antigens; CD3 Complex; Dermatitis, Contact; Dinitrofluorobenzene; Enzyme I

2009